Expression of collagenase-3 (matrix metalloproteinase-13) in human gastric cancer

Gastric Cancer

Volumn 6, Issue 1, 2003, Pages 30-38

  Elnemr, Ayman ^a   Yonemura, Yutaka ^b,d   Bandou, Etsurou ^b   Kinoshita, Kazuo ^b   Kawamura, Taiichi ^b   Takahashi, Shigeru ^b   Tochiori, Shizuka ^c   Endou, Yoshio ^c   Sasaki, Takuma ^c  

^a TANTA UNIVERSITY   (Egypt)

^b SHIZUOKA CANCER CENTER   (Japan)

^c KANAZAWA UNIVERSITY   (Japan)

^d Dept of Gastroenterological Surgery ^*  (Japan)

Author keywords

Collagenase 3; Extracellular matrix components; Invasion; Prognosis

Indexed keywords

COLLAGENASE 3; GELATINASE A; MATRIX METALLOPROTEINASE; MATRIX METALLOPROTEINASE 14; MESSENGER RNA;

ARTICLE; CANCER CELL CULTURE; CANCER INVASION; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; DISEASE COURSE; ENZYME ACTIVATION; ENZYME ACTIVE SITE; ENZYME ACTIVITY; ENZYME LOCALIZATION; ENZYME SPECIFICITY; GENE OVEREXPRESSION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MOUSE; NONHUMAN; PODOCYTE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STATISTICAL SIGNIFICANCE; STOMACH ADENOCARCINOMA; STOMACH MUCOSA; WESTERN BLOTTING; ZYMOGRAPHY;

ADENOCARCINOMA; BLOTTING, SOUTHERN; COLLAGENASES; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; JAPAN; MATRIX METALLOPROTEINASE 13; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASES, MEMBRANE-ASSOCIATED; METALLOENDOPEPTIDASES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; STATISTICS; STOMACH NEOPLASMS; TUMOR CELLS, CULTURED; TUMOR MARKERS, BIOLOGICAL;

EID: 0037267075     PISSN: 14363291     EISSN: None     Source Type: Journal    
DOI: 10.1007/s101200300004     Document Type: Article

References (37)

1. Baba H, Maehara Y, Takeuchi H, Inutsuka S, Okuyama T, Adachi Y, et al. Effect of lymph node dissection on the prognosis in patients with node-negative early gastric cancer. Surgery 1995;117:165-9.
2. Nakazato H, Koike A, Saji S, Ogawa N, Sakamoto J. Efficacy of immunochemotherapy as adjuvant treatment after curative resection of gastric cancer. Study Group of Immunochemotherapy with PSK for Gastric Cancer. Lancet 1994:343:1122-6.
3. Bonenkamp JJ, Songun I, Hermans J, Sasako M, Welvaart K, Plukkere JT, et al. Randomized comparison of morbidity after D1 and D2 dissection for gastric cancer in 996 Dutch patients. Lancet 1995;345:745-8.
4. Docherty AJ, O'Connell J, Crabbe T, Angal S, Murphy G. The matrix metalloproteinases and their natural inhibitors: prospects for treating degenerative tissue diseases. Trends Biotechnol 1992;6:200-7.
5. Liotta LA, Steeg PS, Stetler-Stevenson WG. Cancer metastasis and angiogenesis: an imbalance of positive and negative regulation. Cell 1991;64:327-36.
6. Dano K, Andreasen PA, Grondahl-Hansen J, Kristensen P, Nielsen LS, Skriver L. Plasminogen activators, tissue degradation, and cancer. Adv Cancer Res 1985;44:139-266.
7. Freije JP, Diez-Itzu I, Balbin M, Sanchez LM, Blasco R, Tolivia J, Lopez-Otin C. Molecular cloning and expression of collagenase-3, a novel human matrix metalloproteinase produced by breast carcinomas. J Biol Chem 1994;269:16766-73.
8. Johansson N, Airola K, Grenman R, Kaineimi AL, Saarialho-Kere U, Kahari VM. Expression of collagenase-3 (matrix metalloproteinase-13) in squamous cell carcinomas of the head and neck. Am J Pathol 1997;151:499-508.
9. Uria JA, Balbin M, Lopez JM, Alvarez J, Vizoso F, Takigawa M, Lopez-Otin C. Collagenase-3 (MMP-13) expression in squamous cell carcinomas of the head and neck. Am J Pathol 1998;153:91-101.
10. Bostrom PJ, Ravanti L, Reunanen N, Aaltonen V, Soderstrom KO, Kahari VM, Laato M. Expression of collagenase-3 (matrix metalloproteinase-13) in transitional -cell carcinoma of the urinary bladder. Int J Cancer 2000;88:417-23.
11. Uitto VJ, Airola K, Vaalamo M, Johansson N, Putnins EE, Firth JD, et al. Collagenase-3 (matrix metalloproteinase-13) expression is induced in oral mucosal epithelium during chronic inflammation. Am J Pathol 1998;152:1489-99.
12. Johansson N, Saarialho-Kere U, Airola K, Herva R, Nissinen L, Westermarck J, et al. Collagenase-3 (MMP-13) is expressed by hypertrophic chondrocytes, periosteal cells, and osteoblasts during human fetal bone development. Dev Dyn 1997;208:387-97.
13. Wernicke D, Seyfert C, Hinzmann B, Gromnica-Ihle E. Cloning of collagenase-3 from the synovial membrane and its expression in rheumatoid arthritis. J Reumatol 1996;26:590-5.
14. Knauper V, Will H, Lopez-Otin C, Smith B, Atkinson SJ, Stanton H, et al. Cellular mechanisms for human collagenase-3 (MMP-13) activation: evidence that MT1-MMP (MMP-14) and gelatinase A (MMP-2) are able to generate active enzyme. J Biol Chem 1996;271:17124-31.
15. Knauper V, Lopez-Otin C, Smith B, Knight G, Murphy G. Biochemical characterization of human collagenase-3. J Biol Chem 1996;271:1544-50.
16. Stetler-Stevenson WG, Aznavoorian S, Liotta L. Tumor cell interaction with the extracellular matrix during invasion and metastasis. Annu Rev Biol 1993;9:541-73.
17. Knauper V, Smith B, Lopez-Otin C, Murphy G. Activation of progelatinase B (proMMP-9) by active collagenase-3 (MMP-13). Eur J Biochem 1997;248:369-73.
18. Etoh T, Inoue H, Yoshikawa Y, Barnard GF, Kitano S, Mori M. Increased expression of collagenase-3 (MMP-13) and MT1-MMP in oesophageal cancer is related to cancer aggressiveness. Gut 2000;47:50-6.
19. Yonemura Y, Endo Y, Fujita H, Fushida S, Bandou E, Taniguchi K, et al. Role of MMP-7 in the formation of peritoneal dissemination in gastric cancer. Gastric Cancer 2000;3:63-70.
20. Japanese Research Society for Gastric Cancer. Japanese classification of gastric carcinoma. Tokyo: Kanehara; 1995.
21. Norman A. Polymerase chain reaction strategy. Annu Rev Biochem 1992;61:131-56.
22. Erlich HA, Gelfand D, Sninsky JJ. Recent advances in polymerase chain reaction. Science 1992;252:1643-51.
23. Dubitsky A, Brown J, Brandwein H. Chemiluminescent detection of DNA on nylon membranes. Biotechniques 1992;13:392-400.
24. Hibbs MS, Hasty KA, Seyer JM, Kang AH, Marinardi CLA. Biochemical and immunological characterization of the secreted forms of human neutrophil gelatinase. J Biol Chem 1985;260:2493-500.
25. Kaplan E, Meier P. Nonparametric estimation for incomplete observation. J Am Stat Assoc 1958;53:457-81.
26. Cox DR. Regression models and life tables. J R Stat Soc Ser B 1972;34:187-220.
27. Pie D, Weiss S. Transmembrane-deletion mutants of the membrane-type matrix metalloproteinase-1 process gelatinase A and express intrinsic matrix-degrading activity. J Biol Chem 1996;271:9135-40.
28. Imai K, Ohuchi E, Aoki T, Nomura H, Fujii Y, Sato H, et al. Membrane-type matrix metalloproteinase 1 is a gelatinolyic enzyme and is secreted in a complex with tissue inhibitor of metalloproteinase 2. Cancer Res 1996;56:2707-10.
29. Reboul P, Pelletier JP, Tardif G, Cloutier JM, Martel-Pelletier J. The new collagenase, collagenase-3, is expressed and synthesized by human chondrocytes but not by synoviocytes: a role in osteoarthritis. J Clin Invest 1996;97:2011-9.
30. MacDougall JR, Matrisian LM. contibution of tumor and stromal matrix metalloproteinases to tumor progression, invasion and metastasis. Cancer Metastasis Rev 1995;14:351-62.
31. Johansson N, Vaalamo M, Grenman S, Hietanen S, Klemi P, Saarialho-Kere U, Kahari VM. Collagenase-3 (MMP-13) is expressed by tumor cells in invasive vulvar squamous cell carcinomas. Am J Pathol 1999;154:469-80.
32. Polette M, Nawrocki B, Gilles C, Polette M, Nawrocki B, Gilles C, et al. MT-MMP expression and localisation in human lung and breast cancers. Virchows Arch Pathol 1996;428:29-35.
33. Okada A, Bellocq JP, Rouyer N, Chenard MP, Rio MC, Chambon P, Basset P. Membrane-type matrix metalloproteinase (MT-MMP) gene is expressed in stromal cells of human colon, breast, and head and neck carcinomas. Proc Natl Acad Sci USA 1995;92:2730-4.
34. Mori M, Mimori K, Shiraishi T, Fujie T, Baba K, Kusumoto H. et al. Analysis of MT1-MMP and MMP2 expression in human gastric cancers. Int J Cancer 1997;74:316-21.
35. Bando E, Yonemura Y, Endou Y, Sasaki T, Taniguchi K, Fujita H, et al. Immunohistochemical study of MT-MMP tissue status in gastric carcinoma and correlation with survival analyzed by univariate and multivariate analysis. Oncol Rep 1998;5:1483-8.
36. Yonemura Y, Endo Y, Takino T, Sakamoto K, Bandou E, Kinoshita K, et al. Membrane-type 1 matrix metalloproteinase enhances lymph node metastasis of gastric cancer. Clin Exp Metastas 2000;18:321-7.
37. Kabashima A, Maehara Y, Kakeji Y, Baba H, Koga T, Sugimachi K. Clinicopathological features and overexpression of matrix metalloproteinases in intramucosal gastric carcinoma with lymph node metastasis. Clin Cancer Res 2000;6:3581-4.